(Q38665558)

5 September 2017

1 reference

title

Antithrombotic therapy in acute myocardial infarction: prevention of venous, left ventricular and coronary artery thromboembolism (English)

1 reference

acute myocardial infarction

5 September 2017

1 reference

1 reference

Stein B

1

1 reference

5 September 2017

Fuster V

series ordinal

2

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 July 1989

1 reference

American Journal of Cardiology

5 September 2017

published in

1 reference

5 September 2017

volume

64

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

33B-40B

1 reference

Insights into the pathogenesis of acute ischemic syndromes

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Influence of arterial damage and wall shear rate on platelet deposition. Ex vivo study in a swine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

The pathological basis and microanatomy of occlusive thrombus formation in human coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Anatomic-physiologic links between acute coronary syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Incomplete lysis of thrombus in the moderate underlying atherosclerotic lesion during intracoronary infusion of streptokinase for acute myocardial infarction: quantitative angiographic observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Epidemiology and pathogenesis of venous thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Regional stasis of blood in the dysfunctional left ventricle: echocardiographic detection and differentiation from early thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Endocardial abnormalities in left ventricular aneurysms. A clinicopathologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Plasma-fibrinogen and thromboemboli after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Left Ventricular Thrombi and Cerebral Embolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Left ventricular aneurysm, intraaneurysmal thrombus and systemic embolus in coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Leg-vein thrombosis following myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Prophylactic anticoagulant therapy in the prevention of calf-vein thrombosis after myocardial infarction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Natural history of postoperative deep-vein thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Small Subcutaneous Doses of Heparin in Prevention of Venous Thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

A double-blind trial of low doses of subcutaneous heparin in the prevention of deep-vein thrombosis after myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Preventing thromboembolism after myocardial infarction: effect of low-dose heparin or smoking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Intracardiac thrombi and systemic embolization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Mural thrombi in myocardial infarctions. Prospective evaluation by two-dimensional echocardiography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Fate of left ventricular thrombi in patients with remote myocardial infarction or idiopathic cardiomyopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Comparison of high-dose with low-dose subcutaneous heparin to prevent left ventricular mural thrombosis in patients with acute transmural anterior myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Anticoagulant therapy after acute myocardial infarction. Relation of therapeutic benefit to patient's age, sex, and severity of infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Increased embolic risk in patients with left ventricular thrombi

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

The prevalence and clinical significance of residual myocardial ischemia 2 weeks after uncomplicated non-Q wave infarction: a prospective natural history study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

The effects of early coronary patency on the evolution of myocardial infarction: a prospective arteriographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Diltiazem and reinfarction in patients with non-Q-wave myocardial infarction. Results of a double-blind, randomized, multicenter trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Evidence favoring the use of anticoagulants in the hospital phase of acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Anticoagulants and myocardial infarction. The problems of pooling, drowning, and floating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Antithrombotic therapy after myocardial reperfusion in acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Rethrombosis after reperfusion with streptokinase: importance of geometry of residual lesions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Usefulness of recanalization to luminal diameter of 0.6 millimeter or more with intracoronary streptokinase during acute myocardial infarction in predicting "normal" perfusion status, continued arterial patency and survival at one year

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

A randomized trial of intravenous tissue plasminogen activator for acute myocardial infarction with subsequent randomization to elective coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

AN ASSESSMENT OF LONG-TERM ANTICOAGULANT ADMINISTRATION AFTER CARDIAC INFARCTION. SECOND REPORT OF THE WORKING PARTY ON ANTICOAGULANT THERAPY IN CORONARY THROMBOSIS TO THE MEDICAL RESEARCH COUNCIL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

Long-term anticoagulant therapy after myocardial infarction. Final report of the Veterans Administration cooperative study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2889%2980008-6

10.1016/S0002-9149(89)80008-6

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference